Eterna Therapeutics
ERNA
#11159
Rank
$2.74 M
Marketcap
$1.62
Share price
-0.61%
Change (1 day)
9.46%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -$16.52 Million USD

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$14.11 Million USD, an increase over its 2024 earnings that were of -$37.89 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$16.52 Million17.15%
2025 -$14.11 Million-62.78%
2024 -$37.89 Million84.63%
2023 -$20.53 Million-16.24%
2022 -$24.51 Million-80.08%
2021 -$0.13 Billion1596.7%
2020 -$7.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
$7.78 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-$0.19 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
$15.97 M-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-$19.04 Million 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-$3.87 Million-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
$1.22 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
$0.25 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA